Neill Sun
Pulmonary Hypertension (PH) is a progressive condition characterized by elevated blood pressure in the pulmonary arteries, leading to right heart failure and significant morbidity and mortality. Hemolytic Anemia (HA), a group of disorders characterized by premature destruction of red blood cells, has been increasingly recognized as a potential cause or contributor to pulmonary hypertension. This mini-review explores the pathophysiological mechanisms linking hemolytic anemia to pulmonary hypertension, clinical presentations, diagnostic challenges, management strategies, and outcomes based on current literature and clinical insights.
ఈ కథనాన్ని భాగస్వామ్యం చేయండి
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 